1 Primary outcome 2. Adverse events |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.1 One or more adverse events |
1 |
510 |
Risk Ratio (M‐H, Random, 95% CI) |
1.01 [0.98, 1.05] |
1.2 Treatment‐attributed adverse events |
1 |
510 |
Risk Ratio (M‐H, Random, 95% CI) |
0.81 [0.40, 1.65] |
1.3 Serious adverse events |
1 |
510 |
Risk Ratio (M‐H, Random, 95% CI) |
0.84 [0.54, 1.31] |
1.4 Treatment‐attributed serious adverse events |
1 |
510 |
Risk Ratio (M‐H, Random, 95% CI) |
0.33 [0.01, 8.14] |
1.5 Adverse events that led to discontinuation |
1 |
510 |
Risk Ratio (M‐H, Random, 95% CI) |
1.67 [0.40, 6.90] |